Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

@article{Trachootham2009TargetingCC,
  title={Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?},
  author={Dunyaporn Trachootham and J{\'e}r{\^o}me Alexandre and Peng Huang},
  journal={Nature Reviews Drug Discovery},
  year={2009},
  volume={8},
  pages={579-591}
}
Increased generation of reactive oxygen species (ROS) and an altered redox status have long been observed in cancer cells, and recent studies suggest that this biochemical property of cancer cells can be exploited for therapeutic benefits. Cancer cells in advanced stage tumours frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially eliminate these cells by pharmacological ROS insults. However, the upregulation of… Expand
Molecular Pathways: Reactive Oxygen Species Homeostasis in Cancer Cells and Implications for Cancer Therapy
TLDR
This review describes several potential therapeutic strategies that take advantage of ROS imbalance in cancer cells by further increasing oxidative stress, either alone or in combination with drugs that modulate certain signaling pathways. Expand
Molecular Pathways Molecular Pathways : Reactive Oxygen Species Homeostasis in Cancer Cells and Implications for Cancer Therapy
Reactive oxygen species (ROS) are important in regulating normal cellular processes, but deregulated ROS contribute to the development of various human diseases, including cancers. Cancer cells haveExpand
Targeting antioxidants for cancer therapy.
TLDR
This review discusses the controversial role of ROS in tumorigenesis and especially elaborate on the advantages of targeting ROS scavengers, hence the antioxidant capacity of cancer cells, and how this can be utilized for cancer therapeutics. Expand
Nanoparticles as Tools to Target Redox Homeostasis in Cancer Cells
TLDR
This review discusses the recent advances in the development of integrated anticancer therapies based on nanoparticles engineered to kill cancer cells by raising their ROS setpoint and examines nanoparticle engineered to exploit the metabolic and redox alterations of cancer cells to promote site-specific drug delivery to cancer cells, thus maximizing anticancer efficacy while minimizing undesired side effects on normal tissues. Expand
Modulation of oxidative stress as an anticancer strategy
TLDR
The controversial role of ROS in tumour development and in responses to anticancer therapies is addressed, and the idea that targeting the antioxidant capacity of tumour cells can have a positive therapeutic impact is elaborate. Expand
Targeting ROS for Cancer Therapy
TLDR
Cancer cell metabolism that often appear in the redox imbalance and oxidative stress, in the situation, antioxidant mechanism needs to balance this pressure, which has been the symbol of tumorigenesis. Expand
Reactive Oxygen Species Reduction is a Key Underlying Mechanism of Drug Resistance in Cancer Chemotherapy
TLDR
This review focused on the genetic mechanism of drug mediated induction of ROS generation in sensitive cells and the ROS reduction in drug resistant cancer cells. Expand
Increased Oxidative Stress as a Selective Anticancer Therapy
TLDR
The mechanisms of redox regulation in CSCs and the pivotal role of ROS in anticancer treatment are reviewed. Expand
ROS-Inducing Agents for Cancer Chemotherapy
TLDR
ROS-inducing drugs represent a highly effective group of mechanism-based agents for individual and combined cancer chemotherapies and result in activation of multiple cell death pathways which include inhibition of mammalian target of rapamycin (mTOR) signaling and downregulation of specificity protein (Sp) transcription factors. Expand
Small molecules regulating reactive oxygen species homeostasis for cancer therapy
TLDR
The source and regulation of ROS is introduced, and small molecules that regulate ROS‐related pathways and show efficacy in cancer therapy from the perspective of pharmacophores are focused on. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 185 REFERENCES
Models of reactive oxygen species in cancer.
TLDR
Several in vitro and in vivo models for ROS research are reviewed, highlighting the need for proper experimental models to assess the effects of ROS on biological systems and their underlying mechanisms. Expand
ROS stress in cancer cells and therapeutic implications.
  • H. Pelicano, D. Carney, P. Huang
  • Biology, Medicine
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
  • 2004
TLDR
ROS stress in cancer cells is reviewed, its underlying mechanisms and relationship with mitochondrial malfunction and alteration in drug sensitivity are reviewed, and new therapeutic strategies that take advantage of increased ROS in cancer Cells to enhance therapeutic activity and selectivity are suggested. Expand
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.
TLDR
It is shown that abnormal increases in ROS can be exploited to selectively kill cancer cells using beta-phenylethyl isothiocyanate (PEITC), which exhibits therapeutic activity and prolongs animal survival in vivo. Expand
Oxidative stress and apoptosis: a new treatment paradigm in cancer.
TLDR
Pre-clinical and clinical data regarding novel therapeutic agents that modulate the cellular redox system including buthionine sulfoximine, ascorbic acid, arsenic trioxide, imexon, and motexafin gadolinium as single-agents and in combination are discussed. Expand
Experimental therapeutics: targeting the redox Achilles heel of cancer.
Reactive oxygen species (ROS) have recently emerged as promising targets for anticancer drug discovery. Constitutively elevated levels of cellular oxidative stress and dependence on mitogenic andExpand
Cancer cell killing via ROS: To increase or decrease, that is the question
TLDR
The paradox in the rationales of two opposite ROS-manipulation strategies and the concerns for their use are discussed, as well as a combinational set of cellular parameters including redox status, antioxidant enzymes expression, cell signaling and transcription factor activation profiles, namely "redox signaling signature", is waiting for being developed in order to choose ROS-elevating or ROS-depleting therapy specific to certain type of cancer cells. Expand
Oxidative stress, redox, and the tumor microenvironment.
TLDR
Cellular metabolism is critical for the generation of energy in biological systems; however, as a result of electron transfer reactions, reactive oxygen species (ROS) are generated in aerobic cells, which are capable of countering the effects of oxidative stress by virtue of a complex redox buffering system. Expand
Antioxidant inhibitors for cancer therapy.
TLDR
It is hypothesize that the appropriate administration of antioxidant inhibitors and/or free-radical-generating compounds may be a useful strategy in the treatment of solid tumors. Expand
Reactive oxygen species in oncogenic transformation.
TLDR
ROS-regulated mechanisms that are associated with cancer and tumour invasiveness are described, including mitogenic signalling and cell motility, while ROS have also been implicated in apoptosis and cellular senescence, two mechanisms regarded as being anti-tumorigenic. Expand
Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies
  • P. Karihtala, Y. Soini
  • Chemistry, Medicine
  • APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
  • 2007
TLDR
The present review aims to clarify the significance of oxidative stress and the role of cell redox state modulating systems in human malignancies in light of the current literature. Expand
...
1
2
3
4
5
...